The results suggest that guanethidine and bretylium belong to competitive blocking agents as far as the swaeting axon reflex is concerned.
It has been known that guanethidine and bretylium possess some common pharmacological properties. The sympathetic ganglionic transmission has been reported to be blocked by guanethidine (Maxwell, Mull and Plummer;1 Maxwell, Plummer, Schneider, Povalski and Daniel;2 Bein;3 Gertner and Romano4) and also by bretylium (Boura and Green;5 Green;6 Gertner and Romano4; Shand7). However, the mode of action of both agents in blocking the ganglionic tranmission remains still obscure.
In view of the fact that the receptors for the sweating axon reflex behave like the sympathetic ganglion cells in being stimulated by nicotine and other agents with nicotine-like action (Coon and Rothman;8,9 Rothman and Coon;10 Wada, Arai, Takagaki and Nakagawa11), the present study was undertaken to test the effect of guanethidine and bretylium on the sweating axon reflex in human skin.
METHODS
Eight healthy males whose ages ranged from 20 to 58 years were used as test subjects and their dorsal or volar surface was chosen as a test area. Sweating was visualized as black spots by the iodine-starch method of Wada and Takagaki.12,13
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The axon reflex sweating was identified by the method of Wada et al.11 Details of the procedure were described also in a recent paper from this laboratory to which the reader is referred. 14 Briefly, a rubber band was placed around the forearm at a tension sufficient to interrupt diffusion of a solution which would be injected intradermally to the area closely distal to the band. When sweat response was elicited by an axon reflex mecha nism, the spread of response could not be interrupted by the application of the band. This method is especially advantageous for analyzing the response elicited by an agent having a dual sudorific action, such as acetylcholine with axon reflex provoking action and direct stimulating action on the sweat glands. The observations of sweat response were made under a magnifying lens. The sweating areas were outlined with color pencils at 3, 6, 10 and 15 min after injection.
At the end of the experiment the contours of the areas were transferred to a piece of thin Japanese paper which was placed on the skin of the test area, and the size of the areas was measured with a planimeter.
The effect of guanethidine or bretylium on the axon reflex sweating was evaluated by comparing the latency before the appearance of sweat spots, the extent of sweat response and the density of sweat spots with those on the control forearm. The degree of inhibitory effect on the axon reflex repsonses was classified as slight, intermediate (reduction of about 50 per cent in size), strong and complete, mainly on the basis of comparison of the maximum extent of the axon reflex response with that obtained with the control injection.
For The analysis of the effect of guanethidine or bretylium on the axon reflex was made using the two band method of Wada et al.11 In addition, the effect of guanethidine and bretylium on the neuro-glandular effector system of sweating was studied.
Injection wheals with the test agent, together with a control wheal, were made at appropriate distance from each other, and the axon reflex sweating by nicotine or the thermoregulatory sweating was evoked so as to include the wheals in the response area. Further, the effect of guanethidine and bretylium on the responsiveness of tile sweat glands to acetylcholine, acetyl-beta-methyl-choline and adrenaline was examined. The test agent was injected intradermally in mixture with each of these sudorific agents. The agents were prepared freshly in 0.9% NaCl or in Ringer solution.
Nicotine (Theodor Schuchardt), acetylcholine chloride (Roche), guanethidine sulfate (Ciba), bretylium tosylate (Burrough Wellcome), acetyl-beta-methyl-choline chloride (mecholyl, Merck) and L-adrenaline chloride (Sankyo) were used, and the concentrations of each agent in text were expressed as final concentrations in terms of volume to volume for nicotine and of weight to volume for other agents used.
RESULTS
In preliminary experiments it was established that both guanethidine and bretylium at the concentrations used in the present investigation possess no sudorific action. Then, the effect of the both agents on the sweating axon reflex was studied.
The results obtained are summarized in Table 1 .
1) Effect of guanethidine and bretylium on the sweating axon reflex produced by nicotine
In 39 experiments, control injections of nicotine in a concentration of 10-5, the optimum for evoking the axon reflex sweating, were made intradermally at the site closely distal to the band which had been applied around the forearm at appropriate tension. The pattern of the sweat response elicited thereby was the same as that described by Wada et al."
About 20 to 50 sec, 28.4 sec on an average, after the start of injection sweat spots became visible around the injection wheal and 3 to 10 sec later they appeared also in the area closely proximal to the band. Then the response spread inward to include the wheal and over a wide oval area surrounding the wheal. The maximum extent of 34.0 to 111.7 cm2, 71.4 cm2 on an average, was reached usually within 6 to 10 min, sometimes within 15 min after injection. In one and same subjects the maximum extent varied on different days with standard deviations ranging from 7.1 to 14.4 per cent. 2) Effect of guanethidine and bretylium on the sweating axon reflex produced by acetylcholine
At the optimum concentration of 10-4, acetylcholine has been shown to have a dual sudorific action. In this series of experiments, the band method proved to be most useful in discriminating between the effect of guanethidine or bretylium on the sweat response to the muscarinic action of acetylcholine on the sweat glands and its effect on the axon reflex sweat response to the nicotinic action of acetyl choline. On the uninjected side of the band applied, sweat spots began to appear In this series of experiments the effect was tested of guanethidine in 10-5, 10-4 and 10-3 which had been proved to be sufficient to block strongly or completely the axon reflex response elicited by nicotine and acetylcholine. But, these concentrations of guanethidine were found to have no blocking effect on the axon reflex produced by NaCl. The maximum extent of the response was not significantly changed by guanethidine even at a concentration of 10-3 in all of 10 experiments. In some experiments in which the appearance of response was delayed about 30 sec or more, the size of the response area at 3 min after injec tion was smaller than that obtained with a control injection of NaCl on the op posite forearm, but the maximum extent of the response which was reached during the observation period of 15 min was almost the same as that obtained with the control injection.
Likewise, bretylium in 10-3 was tested on the three subjects, and was found to have no blocking effect on the axon reflex response elicited by NaCl.
It may be added that in these experiments the injection wheal was always devoid of sweat spots, very probably because of hypertonicity of the injected solution.
4) The site of blocking action of guanethidine and bretylium on the sweating axon reflex produced by nicotine and acetylcholine
As described above, the elicitation of the sweating axon reflex by nicotine and acetylcholine was blocked by guanethidine and bretylium, suggesting that both blocking agents may act on the receptors responsible for this reflex. But, the question arises whether these blocking agents affect the conduction of the axon reflex impulses by acting on the sweat nerve fibers.
The analysis of the blocking effect was made by the two-band method of Wada et al.11 The skin area demarcated by two bands which had been placed around the forearm was infiltrated with guanethidine or bretylium in a concentra tion of 10-3. The infiltrated area was about 1.5cm in width and 7cm in length. As a control, the infiltration was made on the opposite forearm with 0.9% NaCl containing neither of the test agents. If this concentration of guanethidine or of bretylium were sufficient to paralyze the efferent nerve fibers responsible, the infiltrated area should act as a barrier to the spread of axon reflex response. In all three subjects, however, the spread of the response elicited by nicotine in 10-5 which was injected into the skin at the site closely distal to the infiltrated zone about 3 min after infiltration was unaffected by either blocking agent. The maximum extent of the response was almost the same as that on the opposite forearm. It was noticed that the area infiltrated with guanethidine in 10-3 was always devoid of sweat spots, whereas that infiltrated with bretylium in 10-3 showed the usual sweat response. In any case, there was no evidence to indicate that the nerve pathways responsible for the axon reflex are blocked by such a high concentration of guanethidine and bretylium. Therefore, it appears reasonable to assume that the site of the blocking action of both agents may be localized at the axon reflex receptors which have been presumed to be specialized portions of the sweat nerve endings.
5) Effect of guanethidine and bretylium on the neuro-glandular effector system of sweating
Boura and Greens reported briefly that intravenous injection of bretylium in a dose of 10 mg/kg did not prevent the sweat response on the cat's paw to stimula tion of the peripheral sympathetic chain. On the other hand, Lloyd15 observed that the galvanic skin response of the foot pad of cats to stimulation of the plantar nerve was blocked by intravenous injection of guanethidine (10mg/kg) and of bretylium (10-20mg/kg). Very recently, Fosters reported that guanethidine decreased the sweat responses of the cat's sweat glands to arterial injection of acetylcholine or mecholyl and also to the sweat nerve stimulation, stating that guanethidine has a competitive anticholinergic action.
As described above, in the experiments with the two-band method it was suggested that guanethidine in 10-3 might have some inhibitory action on the neuro glandular effector system of sweating, at the site of injection. For confirming this, the following experiments were carried out. Injection wheals were produced by intradermal injections of guanethidine in 10-5, 10-4 and 10-3, which were made in 0.9% NaCl or Ringer solution. The wheals were made at a distance of 2 to 4cm from each other. Immediately afterwards sweating was induced on the test area including these wheals by intradermal nicotine in 10-5 or by entering a hot environ-on Sweating Axon Reflex 123 ment. The axon reflex sweat response to nicotine did not occur on the wheal with guanethidine in 10-3 in all 8 tests on 6 subjects at least for the observation period of 10min, and likewise no thermoregulatory sweating developed on the wheal with this concentration of guanethidine in all 3 tests on 3 subjects at least for 20min after injection. On the wheal with guanethidine in 10-4, the inhibition of these responses was slight, if any; and with guanethidine in 10 no inhibition was observed. In contrast, bretylium had no such blocking action even at a concentration of 10-3.
Then, the effect of guanethidine on the responsiveness of the sweat glands to sudorific agents was studied. The threshold and superthreshold concentrations of acetylcholine (10-12, 10-11 and 10-10), mecholyl (10-9, 10-8 and 10-7) and adrenaline (10-7, 10-6 and 10-5) for producing local sweating when injected intradermally were used in a total of ‡V tests on 5 subjects.
At the concentrations of 10-3 and 10-4, guanethidine inhibited completely the sweat response to acetylcholine in the majority of 21 tests, but sometimes a few Fig. 1 . With guanethidine in 10-5, a definite but slight inhibition with a short delay in onset of the response was found only in the response to the threshold concentration of acetylcholine and mecholyl. Further, the sweat response to the threshold concentration (10-7) of adrenaline was abolished always by guanethidine in 10-3 only. From these results, it seems likely to assume that the inhibition by guanethidine in 10-3 of the sweat responses elicited by nervous mechanism may be at least partly due to a reduced responsiveness to acetylcholine of the sweat glands, although there remains the possibility that guanethidine in this concentra tion may affect the transmitter release from the sweat nerve endings. It was noticed that intradermal injection of guanethidine in 10-3 produced always reddening of the skin, which was limited mainly to the injection wheal and continued for 3 to 15 min. As regards the mode of action of guanethidine and bretylium on the ganglionic transmission, our knowledge remains incomplete. It has been reported that both agents have local anesthetic action (Boura and Green;5 Bein;3 Boyd, Chang and Randy). Boura and Green5 explained the ganglionic bock by bretylium as being due to its local anesthetic action. A similar explanation was offered by Boura and Further, in the present experiments it was found that guanethidine and bretylium possess no sudorific action when injected intradermally. If both agents had a depolarizing action on the axon reflex receptors, it might be too weak to elicit the sweating axon reflex by themselves. 
